Telomir Pharmaceuticals Inc. Common Stock (TELO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telomir Pharmaceuticals I...

    NASDAQ: TELO · Real-Time Price · USD
    1.36
    -0.01 (-0.73%)
    At close: Sep 12, 2025, 3:59 PM
    1.38
    1.40%
    After-hours: Sep 12, 2025, 07:55 PM EDT

    Telomir Pharmaceuticals Common Stock Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.36 -15.86 -242.66 -1.5K
    PEG Ratio
    		 -0.27 -0.01 -0.47 n/a
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 189.26 60.28 -221.14 -1.5K
    P/FCF Ratio
    		 -24 -53.7 -442.26 -1.74K
    P/OCF Ratio
    		 -24 -53.7 -442.26 -1.74K
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.15 0.03 -0.62 -0.86
    Quick Ratio
    		 1.94 0.33 0.05 n/a
    Current Ratio
    		 1.94 0.33 0.05 n/a
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 2.82 -2.4 n/a n/a
    Return on Equity
    		 -25.71 -3.8 0.91 1.00
    Return on Assets
    		 -12.49 -2.74 -17.53 n/a
    Return on Invested Capital
    		 -16.62 -1.11 2.77 7.37
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist